2006 annual financial data
Corcept Therapeutics 2006 Operating margin
Direct answer
Operating margin was -8,701.36%.
Operating income was -25,582,000 USD and net income was -24,873,000 USD.
Operating cash flow was -23,238,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 294,000 USD
- Operating income
- -25,582,000 USD
- Net income
- -24,873,000 USD
- Operating cash flow
- -23,238,000 USD